# Galderma (Switzerland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/galderma-switzerland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 12 |
| Citations | 6,878 |
| City | Lausanne |
| Country | CH |
| Description | Galderma (Switzerland) is a research organisation in Lausanne, CH. OpenAlex records 239 works and 6,878 citations for it. 90 researchers list it as their most recent affiliation. |
| Homepage | http://www.galderma.com/ |
| OpenAlex ID | https://openalex.org/I4210163806 |
| Region | Vaud |
| Researchers | 90 |
| ROR ID | https://ror.org/05fswdm20 |
| Type | company |
| Works | 239 |

## University papers

- [Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics](https://scholariq.org/papers/epidemiological-benefits-of-more-effective-tuberculosis-vaccines-drugs-and/)
- [Waiting time distributions in financial markets](https://scholariq.org/papers/waiting-time-distributions-in-financial-markets/)
- [Non-monotonic spontaneous magnetization in a Sznajd-like consensus model](https://scholariq.org/papers/non-monotonic-spontaneous-magnetization-in-a-sznajd-like-consensus-model/)
- [A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America](https://scholariq.org/papers/a-cost-effectiveness-analysis-of-denosumab-for-the-prevention-of-skeletal/)
- [PHASE TRANSITIONS, MEMORY AND FRUSTRATION IN A SZNAJD-LIKE MODEL WITH SYNCHRONOUS UPDATING](https://scholariq.org/papers/phase-transitions-memory-and-frustration-in-a-sznajd-like-model-with-synchronous/)
- [Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain](https://scholariq.org/papers/cost-effectiveness-and-budget-impact-of-routine-use-of-fractional-exhaled-nitric/)
- [RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma](https://scholariq.org/papers/re-mind2-comparative-effectiveness-of-tafasitamab-plus-lenalidomide-versus/)
- [Langevin processes, agent models and socio-economic systems](https://scholariq.org/papers/langevin-processes-agent-models-and-socio-economic-systems/)
- [Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison](https://scholariq.org/papers/ponatinib-vs-imatinib-as-frontline-treatment-for-philadelphia-chromosome/)
- [Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm](https://scholariq.org/papers/modelling-heterogeneity-and-the-impact-of-chemotherapy-and-vaccination-against/)
- [Healthcare Resource Utilization and Economic Burden Across Clinical Phenotypes of Moderate-to-Severe Atopic Dermatitis in United States Dermatology Facilities](https://scholariq.org/papers/healthcare-resource-utilization-and-economic-burden-across-clinical-phenotypes/)

## University researchers

- [Lorenzo Sabatelli](https://scholariq.org/researchers/lorenzo-sabatelli/)

## University top topics

Showing 8 of 24.

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Acne and Rosacea Treatments and Effects](https://scholariq.org/topics/acne-and-rosacea-treatments-and-effects/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)
- [Dermatologic Treatments and Research](https://scholariq.org/topics/dermatologic-treatments-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.